In the current drug discovery process, selecting the appropriate drug target can be as important as optimizing the chemical entity that binds to that target. Even though the explosion of genomics-based drug discovery approaches has led to a large collection of potential drug targets, culling the “druggable” targets from the potential ones is the real challenge.

One way to face this challenge is to use TimeLogic’s accelerated sequence similarity searching hardware for enhancing the genomics projects in drug discovery. Because the search times for large projects are completed in a fraction of the time with the DeCypher technology, you not only increase your discovery time, but you also save money on energy and personnel costs when compared to large cluster systems.